Literature DB >> 17846305

Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database.

Loren F Hiratzka1, Kim A Eagle, Li Liang, Gregg C Fonarow, Kenneth A LaBresh, Eric D Peterson.   

Abstract

BACKGROUND: The American Heart Association Get With the Guidelines-Coronary Artery Disease program facilitates patient and physician compliance with proven atherosclerosis risk reduction strategies with collaborative learning sessions, teaching materials, predischarge online check lists, and web-based performance measure feedback for continuous quality improvement. Patients having coronary artery bypass graft surgery (CABG) may be subject to different care processes, nursing unit pathways, and personnel than patients having percutaneous catheter intervention or neither intervention, which may affect compliance. METHODS AND
RESULTS: The Get With the Guidelines-Coronary Artery Disease database was queried to determine whether compliance with secondary prevention performance measures for CABG patients was different from that for nonsurgical patients. A total of 119,106 patients were treated with CABG (14,118), percutaneous catheter intervention (58,702), or neither intervention (46,286). Compliance with medication prescriptions, including aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs, and smoking cessation counseling for eligible patients was analyzed. Medically appropriate exclusions and contraindications were included in the analysis. After adjusting for 14 clinical variables, CABG patients were less likely to receive most secondary prevention measures relative to percutaneous catheter intervention patients. In contrast, CABG patients were more likely to receive aspirin, beta-blocker, and smoking cessation counseling than neither intervention patients. Composite adherence and defect-free rates were highest for percutaneous catheter intervention patients and lowest for neither intervention patients after adjustment.
CONCLUSIONS: There are significant differences in compliance at hospital discharge with secondary prevention performance measures for CABG patients compared with nonsurgical patients. Process of care differences may explain these differences and should be examined further because significant opportunities for improved compliance are evident. CABG patients in particular represent a group for whom secondary prevention has proven benefits, and they may benefit from future quality improvement interventions.

Entities:  

Mesh:

Year:  2007        PMID: 17846305     DOI: 10.1161/CIRCULATIONAHA.106.681247

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices.

Authors:  Donald S Likosky; Daniel C FitzGerald; Robert C Groom; Dwayne K Jones; Robert A Baker; Kenneth G Shann; C David Mazer; Bruce D Spiess; Simon C Body
Journal:  J Extra Corpor Technol       Date:  2010-06

2.  Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy.

Authors:  Javaid Iqbal; Patrick W Serruys
Journal:  Ann Transl Med       Date:  2017-03

3.  Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes.

Authors:  Dharam J Kumbhani; Brian J Wells; A Michael Lincoff; Anil Jain; Susana Arrigain; Changhong Yu; Marlene Goormastic; Stephen G Ellis; Eugene Blackstone; Michael W Kattan
Journal:  Am J Cardiovasc Dis       Date:  2013-02-17

4.  Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice.

Authors:  Judson B Williams; Elizabeth R Delong; Eric D Peterson; Rachel S Dokholyan; Fang-Shu Ou; T Bruce Ferguson
Journal:  Circulation       Date:  2010-12-20       Impact factor: 29.690

5.  Process of care performance measures and long-term outcomes in patients hospitalized with heart failure.

Authors:  Mark E Patterson; Adrian F Hernandez; Bradley G Hammill; Gregg C Fonarow; Eric D Peterson; Kevin A Schulman; Lesley H Curtis
Journal:  Med Care       Date:  2010-03       Impact factor: 2.983

Review 6.  Post-myocardial Infarction Heart Failure: A Review on Management of Drug Therapies.

Authors:  Gautam Swaroop
Journal:  Cureus       Date:  2022-06-08

7.  Prognostic value of troponin I levels for predicting adverse cardiovascular outcomes in postmenopausal women undergoing cardiac surgery.

Authors:  Joshua D Stearns; Victor G Dávila-Román; Benico Barzilai; Richard E Thompson; Kelly L Grogan; Betsy Thomas; Charles W Hogue
Journal:  Anesth Analg       Date:  2009-03       Impact factor: 5.108

8.  European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Int J Behav Med       Date:  2012-12

9.  The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.

Authors:  Natasha K Wolfe; Joshua D Mitchell; David L Brown
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2021-07-21

10.  Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.

Authors:  Heng Zhang; Xin Yuan; Haibo Zhang; Sipeng Chen; Yan Zhao; Kun Hua; Chenfei Rao; Wei Wang; Hansong Sun; Shengshou Hu; Zhe Zheng
Journal:  Circulation       Date:  2015-04-23       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.